ST
GSK icon

Spot Trading’s GSK GSK Stock Holding History

Spot Trading’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$633K Sell
12,480
-47,360
-79% -$2.4M 0.01% 1477
2017
Q2 		$3.23M Buy
59,840
+5,760
+11% +$307K 0.06% 397
2017
Q1 		$2.85M Sell
54,080
-4,240
-7% -$215K 0.09% 221
2016
Q4 		$2.81M Buy
58,320
+44,960
+337% +$2.22M 0.07% 408
2016
Q3 		$720K Sell
13,360
-23,680
-64% -$1.3M 0.01% 1288
2016
Q2 		$2.01M Sell
37,040
-9,360
-20% -$493K 0.03% 686
2016
Q1 		$2.35M Buy
46,400
+1,280
+3% +$63.8K 0.04% 603
2015
Q4 		$2.28M Buy
45,120
+18,960
+72% +$966K 0.02% 924
2015
Q3 		$1.26M Sell
26,160
-10,240
-28% -$533K 0.01% 1402
2015
Q2 		$1.9M Buy
36,400
+17,040
+88% +$959K 0.02% 1178
2015
Q1 		$1.12M Sell
19,360
-78,960
-80% -$4.53M 0.01% 1508
2014
Q4 		$5.25M Sell
98,320
-24,720
-20% -$1.38M 0.03% 766
2014
Q3 		$7.07M Buy
123,040
+6,720
+6% +$412K 0.04% 730
2014
Q2 		$7.78M Buy
116,320
+36,000
+45% +$2.44M 0.04% 691
2014
Q1 		$5.36M Buy
80,320
+61,200
+320% +$4.14M 0.03% 809
2013
Q4 		$1.28M Buy
19,120
+2,560
+15% +$166K 0.01% 1799
2013
Q3 		$1.04M Buy
16,560
+1,280
+8% +$82.4K 0.01% 1877
2013
Q2 		$954K Buy
+15,280
New +$970K 0.01% 1939

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Spot Trading's GSK Position: Q3 2017 in Review

Spot Trading sold out of GSK (GSK) in Q3 2017, closing a stake of 1,827 shares — an estimated $92.7K sold.

Spot Trading first reported a position in GSK in Q2 2013 and held it in 14 quarters. The position peaked at $4.61M in Q3 2014. 741 funds tracked by Wall St. Rank hold GSK as of Q3 2017.

  • Spot Trading reported no remaining GSK position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 1,827 GSK shares in Q3 2017, an estimated $92.7K.
  • Spot Trading first reported a position in GSK in Q2 2013 and held it in 14 quarters.
  • Spot Trading's GSK position peaked at $4.61M in Q3 2014.
  • 741 funds tracked by Wall St. Rank held GSK as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.